TTM Technologies (TTMI) Q3 2026 Earnings Call Transcript

TTM Technologies reported Q3 2026 sales of $1.2 billion, up 60% year over year, and non-GAAP EPS of $1.46, up 118%; adjusted EBITDA margin rose 400bps to 20.1%. The company raised FY2026 guidance to $4.47 billion–$4.49 billion in revenue and issued initial FY2027 revenue guidance of $6.5 billion–$6.75 billion, citing AI-related data-center demand and strength across end markets. TTM also announced a planned $650 million Ophir acquisition and $400 million in capacity investment; management flagged higher borrowing costs, material lead times of up to 24 weeks, and a customer program timing shift.

Analysis

The key underwriting question is not whether AI demand is strong, but whether TTMI can convert a concentrated, program-timed N+M ramp into durable gross-margin and cash-flow gains while funding expansion. Higher-value N+M mix could lift margins, but the customer-side schedule slip and longer material lead times show that bookings can translate unevenly into quarterly shipments. A 2.13 book-to-bill is supportive, not a guarantee: the 90-day backlog is cancellable, and a small number of large programs may create volatility.

Near term, Q4 execution and the delayed program’s production ramp are the main tests; watch revenue conversion, gross margin, and working-capital use. Over 1–3 months, Penang approaching breakeven would support margins, while material availability and customer timing could frustrate guidance. Over 6–18 months, the $400 million capacity plan and planned Ophir close add execution and balance-sheet risk alongside growth potential. Management’s 2027 outlook is ambitious; acquisition contribution, close timing, and incremental interest assumptions need reconciliation against filings, particularly given the transcript’s inconsistent acquisition/timing references.

Contrarian point: margin improvement may be real, but extrapolating it assumes both favorable mix and smooth ramping. Do not capitalize the full 2027 growth outlook before revenue conversion and cash generation confirm it. The thesis weakens if N+M shipments slip again, gross margin reverses, or leverage/interest costs rise faster than EBITDA.

Key Decisions for Investors

• Avoid chasing the immediate earnings strength. Consider a staged long in TTMI on post-event weakness, adding only after the next report confirms N+M revenue conversion and holds or improves gross margin; without current valuation and price data, do not set a numeric target.
• For the next 1–3 months, monitor the delayed N+M program’s Q1 production ramp, material lead times, and the gap between bookings and recognized sales. A further schedule push or deterioration in gross margin is a reason to reduce or exit the long thesis.
• Track quarterly free cash flow against the $400 million capacity commitment and debt-service burden. Verify the acquisition close schedule, expected acquired contribution, and incremental interest expense in company filings; weaker cash conversion or higher-than-guided leverage would invalidate the growth-with-self-funding case.
• Reassess after the next earnings release: the bullish case requires revenue to track the 2027 outlook while margins remain supported by mix and Penang execution—not bookings alone.